Bon Natural Life (BON) Cash & Equivalents (2020 - 2025)

Bon Natural Life (BON) has 6 years of Cash & Equivalents data on file, last reported at $6.3 million in Q3 2025.

• Cash & Equivalents for Q3 2025 came in at $6.3 million, up 7687.11% year-over-year; the trailing twelve-month figure through Sep 2025 was $6.3 million (up 7687.11% YoY), and the FY2025 annual result was $6.3 million, up 7687.11% from the prior year.
• Cash & Equivalents retreated to $6.3 million in Q3 2025 per BON's latest filing, from $6.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $6.3 million in Q1 2025 and troughed at $1517.0 in Q3 2023.
• A 5-year average of $2.1 million and a median of $1.2 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2025: Cash & Equivalents sank 99.82% in 2023, then soared 7687.11% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $1.9 million in 2021, then slumped by 55.83% to $840861.0 in 2022, then slumped by 99.82% to $1517.0 in 2023, then jumped by 5204.28% to $80466.0 in 2024, then soared by 7687.11% to $6.3 million in 2025.
• Business Quant data shows BON's Cash & Equivalents at $6.3 million in Q3 2025, $6.3 million in Q1 2025, and $80466.0 in Q3 2024.